| Univariate |
P-value |
OR |
95% CI |
Multivariate |
P-value |
Adjusted OR |
95% CI |
| Age (per year) |
<0.001 |
1.056 |
1.033 – 1.081 |
Age (per year) |
<0.001 |
1.058 |
1.033 – 1.084 |
| Gender male |
0.198 |
0.707 |
0.417 – 1.199 |
Killip Class >1 |
<0.001 |
3.253 |
1.7438 – 6.089 |
| BMI |
0.165 |
0.950 |
0.884 – 1.021 |
TIMI flow post PCI <3 |
0.2343 |
1.556 |
0.741 – 3.268 |
| Current smoker |
0.050 |
0.608 |
0.370 – 1.000 |
Tirofiban study medication |
0.768 |
1.080 |
0.646 – 1.807 |
| Diabetes |
0.103 |
1.735 |
0.895 – 3.364 |
NT-proBNP baseline (per 1000 increase) |
0.162 |
1.065 |
0.975 – 1.164 |
| Hypertension |
0.850 |
1.050 |
0.633 – 1.742 |
|
|
|
|
| Hypercholesterolaemia |
0.965 |
1.012 |
0.585 – 1.750 |
|
|
|
|
| Killip Class >1 |
<0.001 |
2.868 |
1.601 – 5.135 |
|
|
|
|
| Previous MI |
0.998 |
1.001 |
0.417 – 2.400 |
|
|
|
|
| Previous PCI |
0.662 |
0.810 |
0.315 – 2.082 |
|
|
|
|
| Previous CABG |
0.955 |
0.942 |
0.120 – 7.400 |
|
|
|
|
| Systolic BP (per 10 mm Hg) |
0.111 |
0.920 |
0.831 – 1.019 |
|
|
|
|
| Diastolic BP (per 10 mm Hg) |
0.202 |
0.900 |
0.765 – 1.058 |
|
|
|
|
| Tirofiban study medication |
0.752 |
1.081 |
0.668 – 1.747 |
|
|
|
|
| Culprit Vessel RCA* |
0.956 |
1.023 |
0.458 – 2.286 |
|
|
|
|
| Culprit Vessel LAD* |
0.992 |
1.004 |
0.444 – 2.272 |
|
|
|
|
| TIMI grade flow post PCI <3 |
0.023 |
2.183 |
1.116 – 4.272 |
|
|
|
|
| NT-proBNP baseline (per 1000 increase) |
0.010 |
1.128 |
1.029 – 1.236 |
|
|
|
|
| HScTnT (per 0.1 increase) |
0.135 |
1.010 |
0.997 – 1.024 |
|
|
|
|
